Catherine Broome, Danny Hsu, Philip Choi, Charlie Zhou, Neelufar Mozaffarian. "Trial in progress: A phase 1b, open-label, multiple ascending dose study of OM336, a novel BCMAxCD3 T cell engager, in patients with relapsed/refractory autoimmune cytopenias (NCT07083960)." Blood, 2025. doi:10.1182/blood-2025-2900